Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of INR 260.67 billion. The enterprise value is 233.74 billion.

Market Cap	260.67B
Enterprise Value	233.74B

Important Dates

The next estimated earnings date is Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	Jul 9, 2025

Share Statistics

Current Share Class	45.75M
Shares Outstanding	n/a
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	15.12M

Valuation Ratios

The trailing PE ratio is 33.96 and the forward PE ratio is 37.06.

PE Ratio	33.96
Forward PE	37.06
PS Ratio	11.43
PB Ratio	6.18
P/TBV Ratio	7.11
P/FCF Ratio	41.27
P/OCF Ratio	39.51
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 31.58, with an EV/FCF ratio of 37.01.

EV / Earnings	30.45
EV / Sales	10.25
EV / EBITDA	31.58
EV / EBIT	34.40
EV / FCF	37.01

Financial Position

The company has a current ratio of 6.17, with a Debt / Equity ratio of 0.03.

Current Ratio	6.17
Quick Ratio	5.26
Debt / Equity	0.03
Debt / EBITDA	0.15
Debt / FCF	0.17
Interest Coverage	80.79

Financial Efficiency

Return on equity (ROE) is 19.65% and return on invested capital (ROIC) is 10.60%.

Return on Equity (ROE)	19.65%
Return on Assets (ROA)	9.29%
Return on Invested Capital (ROIC)	10.60%
Return on Capital Employed (ROCE)	15.65%
Revenue Per Employee	13.26M
Profits Per Employee	4.46M
Employee Count	1,721
Asset Turnover	0.50
Inventory Turnover	1.78

Taxes

In the past 12 months, Pfizer has paid 2.48 billion in taxes.

Income Tax	2.48B
Effective Tax Rate	24.46%

Stock Price Statistics

The stock price has increased by +23.61% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+23.61%
50-Day Moving Average	5,039.84
200-Day Moving Average	4,947.33
Relative Strength Index (RSI)	62.13
Average Volume (20 Days)	2,247

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pfizer had revenue of INR 22.81 billion and earned 7.68 billion in profits. Earnings per share was 167.79.

Revenue	22.81B
Gross Profit	14.71B
Operating Income	6.79B
Pretax Income	10.16B
Net Income	7.68B
EBITDA	7.40B
EBIT	6.79B
Earnings Per Share (EPS)	167.79

Full Income Statement

Balance Sheet

The company has 28.01 billion in cash and 1.08 billion in debt, giving a net cash position of 26.93 billion.

Cash & Cash Equivalents	28.01B
Total Debt	1.08B
Net Cash	26.93B
Net Cash Per Share	n/a
Equity (Book Value)	42.17B
Book Value Per Share	921.88
Working Capital	29.43B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.60 billion and capital expenditures -281.50 million, giving a free cash flow of 6.32 billion.

Operating Cash Flow	6.60B
Capital Expenditures	-281.50M
Free Cash Flow	6.32B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 64.47%, with operating and profit margins of 29.78% and 33.65%.

Gross Margin	64.47%
Operating Margin	29.78%
Pretax Margin	44.54%
Profit Margin	33.65%
EBITDA Margin	32.45%
EBIT Margin	29.78%
FCF Margin	27.69%

Dividends & Yields

This stock pays an annual dividend of 165.00, which amounts to a dividend yield of 2.95%.

Dividend Per Share	165.00
Dividend Yield	2.95%
Dividend Growth (YoY)	371.43%
Years of Dividend Growth	n/a
Payout Ratio	20.88%
Buyback Yield	0.01%
Shareholder Yield	2.95%
Earnings Yield	2.94%
FCF Yield	2.42%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5